Barbara Weber

Director; Director, Director, Executive Chair · 2 filings · Latest: Jun 9, 2026

Parabilis Medicines, Inc.

Tango Therapeutics, Inc.

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TNGX	Barbara Weber	Director, Director, Executive Chair	Feb 3, 2026	Sale	$12.26	30,519	$374.3K	1,629,254	Feb 5 1:09 AM
RVMD	BARBARA L WEBER	—	Oct 8, 2024	Proposed Sale	$47.34	5,200	$246.2K	—	Oct 8 8:23 PM